fda drug shortages tirzepatide zepbound shortage status 2025 Hims: Is Tomorrow the End of the GLP-1 Shortage? Is Tirzepatide Legal in 2026?

For prescribers and patients used to seeing copper peptide injectables sold through grey-market suppliers, the regulatory message has not changed: compounding pharmacies cannot legally produce injectable GHK-Cu from bulk substance under 503A

Serum B12, and potentially methylmalonic acid (MMA) and homocysteine, give your clinician the data to determine whether B12 is a contributing factor or whether the mood symptoms are being driven by something else entirely

Rai said the additional five years, stretching the patent from 2026 to 2031, likely stem from the Hatch-Waxman Act, a 1984 law that allows drugmakers to extend patents by up to five years to make up for time lost moving their drug through clinical trials and the FDA approval process

On Leilanis most recent visit I added Ozempic to her regimen, which will not only improve her glucose levels and reduce excess weight, but will also have beneficial effects on reducing the progression of diabetic kidney disease